Skip to main content
. 2024 Nov 25;10(6):00164-2024. doi: 10.1183/23120541.00164-2024

FIGURE 1.

FIGURE 1

a) Change from baseline to week 52 in pre-bronchodilator FEV1 and b) AAER over 52 weeks in patients with and without PAO at baseline. n indicates the number of patients who contributed to the analysis. AAER: annualised asthma exacerbation rate; FEV1: forced expiratory volume in 1 s; LS: least-squares; PAO: persistent airflow obstruction; Q4W: every 4 weeks.